Bruker Acquires Canopy Biosciences

Bruker Corp. has acquired Canopy Biosciences, a specialist in high multiplex biomarker imaging for immunology, immune-oncology, and cell therapy. The acquisition expands Bruker’s offerings in targeted multiomics and fluorescence-based imaging techniques. Financial details of the transaction have not been disclosed.

Bruker also recently announced the appointment of Bonnie H. Anderson to its board of directors.





LATEST NEWS

• HOLOEYE Partners with Fraunhofer IPMS on Microdisplay
  Nov 22, 2024
• PI Expands German Production Site: Week in Brief: 11/22/24
  Nov 22, 2024
• Lightsynq Emerges from Stealth with $18M Series A
  Nov 21, 2024
• REMBRANDT Project Collaborators to Advance Microwave Photonics
  Nov 21, 2024
• Quasicrystals Create Light Vortices to Transmit More Data with Fiber Optics
  Nov 21, 2024
• Study Finds Laser Light Can Cast a Shadow
  Nov 20, 2024
• Lumicell Adds CEO: People in the News: 11/20/24
  Nov 20, 2024
• AeroVironment to Acquire BlueHalo in $4.1B Transaction
  Nov 20, 2024